|

The Gynecological Cancer Associated Thrombosis (GynCAT) Study

RECRUITINGSponsored by Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Actively Recruiting
SponsorFondazione Policlinico Universitario Agostino Gemelli IRCCS
Started2024-04-15
Est. completion2026-09-30
Eligibility
Age18 Years+
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06284343

Summary

GynCAT is a prospective cohort study that will be conducted on female patients with gynecologic malignancies scheduled for systemic antineoplastic treatment, aiming at development and validation of a Risk Assessment Model (RAM) for Venous Thromboembolism (VTE) in this specific population.

Eligibility

Age: 18 Years+Sex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

* Female sex;
* Diagnosis of gynecologic neoplasm (ovarian, tubal, uterine, cervical, vaginal, vulvar neoplasm);
* Planned new line of systemic antineoplastic treatment;
* Age of 18 years or older;
* Accordance of Informed Consent.

Exclusion Criteria:

* Pregnant or breastfeeding women;
* Indication to receive therapeutic dose anticoagulant therapy (e.g., atrial fibrillation, mechanical heart valve);
* Diagnosis of symptomatic VTE at the time of screening for enrollment.

Conditions8

CancerCancer-associated ThrombosisCervix CancerEndometrial CancerGynecologic CancerOvarian CancerVaginal CancerVenous Thromboembolism

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.